Annaliesa Anderson
Annaliesa is the Senior Vice President and Chief Vaccines Officer at Pfizer. She received her PhD from the University of Warwick and has over 30 years of pharmaceutical research and development experience, contributing to the licensure of numerous vaccines and therapeutics, including against pneumococcal disease, meningococcal disease, RSV and COVID-19.
Abstracts this author is presenting:
